Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

Seeking Alpha • Nov 11, 2025

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

Seeking Alpha • May 30, 2025

Top Performing Leveraged/Inverse ETFs: 05/11/2025

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

ETF Trends • May 14, 2025

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

Seeking Alpha • Feb 25, 2025

Top Performing Leveraged/Inverse ETFs: 11/17/2024

Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

ETF Trends • Nov 19, 2024

3 ETFs in “Oversold” Territory to Start the Week

Technical analysis can tell investors a lot about both stocks and ETFs, including when some might have been overbought, or even oversold.

ETF Trends • Dec 5, 2022

2 ETFs to Watch for Outsized Volume on Internet & Inverse Leveraged Biotech

Inverse leveraged biotech ETF and internet ETF traded with an outsized volume on Friday.

Zacks Investment Research • Oct 10, 2022

Purchase Levels Of 31 Short ETFs Signal Bear Market Bottom (Technical Analysis)

We are bearish on all American bear market ETFs. Measuring the purchase levels of short ETFs replaces the old, odd lot and total short selling indicators so popular in the 1960s, 70s and 80s.

Seeking Alpha • Aug 8, 2022

Cap-Weighting Crucial When Indexing Biotech

The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap companies that don't yet have steady revenue streams because their new drug or treatment is still in development, hasn't received FDA approval, or hasn't been in the market long enough to establish a proven track record.

ETF Trends • Jan 25, 2022